USANA Health Sciences Company Profile (NYSE:USNA)

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences logoUSANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Personal Products - NEC
  • Sub-Industry: Personal Products
  • Symbol: NYSE:USNA
  • CUSIP: 90328M10
  • Web: www.usana.com
Capitalization:
  • Market Cap: $1.43 billion
  • Outstanding Shares: 24,445,000
Average Prices:
  • 50 Day Moving Avg: $59.98
  • 200 Day Moving Avg: $60.27
  • 52 Week Range: $52.55 - $75.00
P/E:
  • Trailing P/E Ratio: 14.91
  • Foreward P/E Ratio: 13.47
  • P/E Growth: 1.48
Sales & Book Value:
  • Annual Revenue: $1.02 billion
  • Price / Sales: 1.40
  • Book Value: $15.56 per share
  • Price / Book: 3.77
Profitability:
  • EBIDTA: $147.32 million
  • Net Margins: 9.47%
  • Return on Equity: 28.93%
  • Return on Assets: 20.74%
Debt:
  • Current Ratio: 2.44%
  • Quick Ratio: 1.93%
Misc:
  • Average Volume: 117,781 shs.
  • Beta: 1.1
  • Short Ratio: 8.18
 

Frequently Asked Questions for USANA Health Sciences (NYSE:USNA)

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences declared that its board has authorized a stock buyback program on Wednesday, July 26th 2017, which allows the company to repurchase $64,600,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 46% of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board of directors believes its stock is undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, July, 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.06 by $0.08. The company earned $257.10 million during the quarter, compared to analysts' expectations of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The company's revenue was down .5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.07 EPS. View USANA Health Sciences' Earnings History.

When will USANA Health Sciences make its next earnings announcement?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences issued an update on its FY17 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $3.50-3.70 for the period, compared to the Thomson Reuters consensus estimate of $4.06. The company issued revenue guidance of $1.02-1.03 billion, compared to the consensus revenue estimate of $1.07 billion.

Where is USANA Health Sciences' stock going? Where will USANA Health Sciences' stock price be in 2017?

1 equities research analysts have issued 12-month price objectives for USANA Health Sciences' shares. Their forecasts range from $70.00 to $70.00. On average, they expect USANA Health Sciences' share price to reach $70.00 in the next twelve months. View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:

  • Myron W. Wentz Ph.D., Chairman, Independent Director
  • Jim Brown, President, Chief Operating Officer
  • Kevin G. Guest, Chief Executive Officer, Independent Director
  • G. Douglas Hekking, Chief Financial Officer
  • Josh Foukas, Executive Vice President - Legal
  • Brent Neidig, Executive Vice President - China
  • Walter Noot, Chief Information Officer
  • Douglas Braun, Chief Marketing Officer
  • Robert A. Sinnott Ph.D, Chief Scientific Officer
  • James H. Bramble, Chief Legal Officer and Corporate Secretary

Who owns USANA Health Sciences stock?

USANA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (7.79%), FMR LLC (6.39%), Vanguard Group Inc. (3.92%), Dimensional Fund Advisors LP (2.84%), Schroder Investment Management Group (2.29%) and Nordea Investment Management AB (1.34%). Company insiders that own USANA Health Sciences stock include Dave Wentz, Deborah Woo, Doug Braun, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jerry G Mcclain, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Rick Stambaugh and Robert Auciaux. View Institutional Ownership Trends for USANA Health Sciences.

Who sold USANA Health Sciences stock? Who is selling USANA Health Sciences stock?

USANA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Citadel Advisors LLC, Menta Capital LLC, Prudential Financial Inc., Spark Investment Management LLC, Tudor Investment Corp ET AL, Acadian Asset Management LLC and Citigroup Inc.. Company insiders that have sold USANA Health Sciences stock in the last year include Deborah Woo, Gilbert A Fuller, Global Ltd Gull, James Bramble, Myron W Wentz, Paul A Jones and Robert Auciaux. View Insider Buying and Selling for USANA Health Sciences.

Who bought USANA Health Sciences stock? Who is buying USANA Health Sciences stock?

USANA Health Sciences' stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, FMR LLC, Old Mutual Global Investors UK Ltd., Schroder Investment Management Group, TIAA CREF Investment Management LLC, Vanguard Group Inc. and GSA Capital Partners LLP. View Insider Buying and Selling for USANA Health Sciences.

How do I buy USANA Health Sciences stock?

Shares of USANA Health Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USANA Health Sciences stock can currently be purchased for approximately $58.60.


MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)
Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  228
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for USANA Health Sciences (NYSE:USNA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $70.00 (19.45% upside)

Analysts' Ratings History for USANA Health Sciences (NYSE:USNA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/26/2017Pivotal ResearchLower Price TargetBuy -> Buy$75.00 -> $70.00HighView Rating Details
7/28/2016DA DavidsonBoost Price TargetNeutral$135.00 -> $150.00N/AView Rating Details
11/4/2015Canaccord GenuityReiterated RatingHold$131.00N/AView Rating Details
10/16/2015SidotiUpgradeNeutral -> Buy$156.00N/AView Rating Details
(Data available from 8/23/2015 forward)

Earnings

Earnings History for USANA Health Sciences (NYSE:USNA)
Earnings by Quarter for USANA Health Sciences (NYSE:USNA)
Earnings History by Quarter for USANA Health Sciences (NYSE USNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017N/AView Earnings Details
7/25/2017Q2 2017$1.06$0.98$273.61 million$257.10 millionViewN/AView Earnings Details
5/2/2017Q1 2017$0.92$0.91$255.32 millionViewListenView Earnings Details
2/7/2017Q416$0.94$0.87$253.52 million$252.90 millionViewListenView Earnings Details
10/25/2016Q316$2.13$2.40$263.37 million$254.22 millionViewListenView Earnings Details
7/26/2016Q2$2.05$2.07$256.66 million$258.50 millionViewListenView Earnings Details
5/3/2016Q116$1.81$1.77$244.05 million$240.45 millionViewListenView Earnings Details
2/9/2016Q415$2.00$1.83$250.82 million$232.60 millionViewListenView Earnings Details
11/3/2015Q315$1.76$1.92$230.79 million$233.30 millionViewListenView Earnings Details
8/4/2015Q215$1.60$1.92$211.86 million$233.20 millionViewListenView Earnings Details
5/5/2015Q1$1.30$1.50$198.21 million$219.40 millionViewListenView Earnings Details
2/10/2015Q414$1.93$1.65$219.10 million$227.90 millionViewListenView Earnings Details
10/28/2014Q314$1.37$1.47$190.50 million$191.90 millionViewListenView Earnings Details
7/29/2014Q214$1.50$1.36$198.30 million$188.30 millionViewListenView Earnings Details
4/29/2014Q114$1.30$1.15$185.85 million$182.40 millionViewListenView Earnings Details
2/5/2014Q413$1.22$1.41$175.53 million$186.30 millionViewListenView Earnings Details
10/23/2013Q313$1.14$1.16$172.40 million$173.70 millionViewListenView Earnings Details
7/23/2013Q2 2013$1.33$1.72$176.60 million$189.10 millionViewListenView Earnings Details
4/23/2013Q1 2013$1.16$1.28$171.77 million$169.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$1.21$1.27$165.80 million$168.50 millionViewListenView Earnings Details
10/23/2012$1.06$1.18ViewN/AView Earnings Details
7/24/2012$0.92$1.11ViewN/AView Earnings Details
2/7/2012$0.86$0.87ViewN/AView Earnings Details
10/25/2011$0.76$0.81ViewN/AView Earnings Details
4/26/2011$0.66$0.70ViewN/AView Earnings Details
2/8/2011$0.84$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for USANA Health Sciences (NYSE:USNA)
Current Year EPS Consensus Estimate: $3.79 EPS
Next Year EPS Consensus Estimate: $4.35 EPS

Dividends

Dividend History for USANA Health Sciences (NYSE:USNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for USANA Health Sciences (NYSE:USNA)
Insider Ownership Percentage: 53.20%
Institutional Ownership Percentage: 43.57%
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)
Insider Trades by Quarter for USANA Health Sciences (NYSE:USNA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2017James BrambleInsiderSell18,298$57.01$1,043,168.98View SEC Filing  
8/2/2017Global Ltd GullMajor ShareholderSell14,533$56.71$824,166.43View SEC Filing  
8/2/2017Myron W WentzDirectorSell40,000$56.59$2,263,600.00View SEC Filing  
8/1/2017Global Ltd GullMajor ShareholderSell25,467$56.52$1,439,394.84View SEC Filing  
7/31/2017Gilbert A FullerDirectorSell1,483$57.67$85,524.61View SEC Filing  
7/5/2017Myron W WentzDirectorSell40,000$64.15$2,566,000.00View SEC Filing  
6/2/2017Myron W WentzDirectorSell40,000$64.99$2,599,600.00View SEC Filing  
6/1/2017Paul A JonesInsiderSell9,851$64.50$635,389.50View SEC Filing  
5/11/2017Gilbert A FullerDirectorSell4,884$64.38$314,431.92View SEC Filing  
5/1/2017Myron W WentzDirectorSell40,000$56.39$2,255,600.00View SEC Filing  
4/5/2017Global Ltd GullMajor ShareholderSell16,436$56.54$929,291.44View SEC Filing  
4/5/2017Myron W WentzDirectorSell40,000$56.81$2,272,400.00View SEC Filing  
4/4/2017Global Ltd GullMajor ShareholderSell10,040$56.69$569,167.60View SEC Filing  
4/3/2017Global Ltd GullMajor ShareholderSell13,524$57.22$773,843.28View SEC Filing  
3/8/2017Global Ltd GullMajor ShareholderSell20,000$57.15$1,143,000.00View SEC Filing  
2/8/2017Global Ltd GullMajor ShareholderSell20,000$55.87$1,117,400.00View SEC Filing  
1/11/2017Myron W WentzDirectorSell20,000$61.04$1,220,800.00View SEC Filing  
12/14/2016Myron W WentzDirectorSell20,000$61.41$1,228,200.00View SEC Filing  
11/9/2016Myron W WentzDirectorSell10,000$123.99$1,239,900.00View SEC Filing  
10/12/2016Global Ltd GullMajor ShareholderSell10,000$146.35$1,463,500.00View SEC Filing  
9/14/2016Global Ltd GullMajor ShareholderSell10,000$134.67$1,346,700.00View SEC Filing  
9/8/2016Deborah WooInsiderSell1,058$140.00$148,120.00View SEC Filing  
8/30/2016Paul A JonesCFOSell5,067$138.50$701,779.50View SEC Filing  
8/23/2016Deborah WooInsiderSell2,621$138.94$364,161.74View SEC Filing  
8/23/2016Robert AuciauxDirectorSell2,317$138.79$321,576.43View SEC Filing  
8/19/2016Deborah WooInsiderSell4,590$133.12$611,020.80View SEC Filing  
8/18/2016Deborah WooInsiderSell5,041$131.15$661,127.15View SEC Filing  
8/16/2016James BrambleInsiderSell9,339$131.33$1,226,490.87View SEC Filing  
8/16/2016Jim BrownCOOSell9,104$131.36$1,195,901.44View SEC Filing  
8/15/2016Kevin GuestInsiderSell16,285$131.08$2,134,637.80View SEC Filing  
8/10/2016Global Ltd GullMajor ShareholderSell10,000$135.08$1,350,800.00View SEC Filing  
8/1/2016Gilbert A. FullerDirectorSell859$137.07$117,743.13View SEC Filing  
7/13/2016Global Ltd GullMajor ShareholderSell10,000$118.96$1,189,600.00View SEC Filing  
6/8/2016Global Ltd GullMajor ShareholderSell10,000$123.47$1,234,700.00View SEC Filing  
6/7/2016Dave WentzInsiderSell10,000$125.09$1,250,900.00View SEC Filing  
5/11/2016Global Ltd GullMajor ShareholderSell10,000$122.67$1,226,700.00View SEC Filing  
4/13/2016Global Ltd GullMajor ShareholderSell10,000$121.82$1,218,200.00View SEC Filing  
3/9/2016Myron W WentzDirectorSell10,000$116.07$1,160,700.00View SEC Filing  
3/4/2016Jerry G McclainDirectorSell767$118.17$90,636.39View SEC Filing  
2/24/2016Gilbert A FullerDirectorSell728$113.22$82,424.16View SEC Filing  
2/10/2016Global Ltd GullMajor ShareholderSell10,000$96.37$963,700.00View SEC Filing  
1/13/2016Global Ltd GullMajor ShareholderSell10,000$121.04$1,210,400.00View SEC Filing  
12/17/2015Rick StambaughinsiderSell7,059$130.18$918,940.62View SEC Filing  
12/16/2015Doug BraunCMOSell10,907$130.80$1,426,635.60View SEC Filing  
12/15/2015Dave WentzInsiderSell6,000$130.59$783,540.00View SEC Filing  
12/15/2015Doug BraunCMOSell2,748$132.00$362,736.00View SEC Filing  
12/9/2015Myron W WentzDirectorSell10,000$133.18$1,331,800.00View SEC Filing  
11/11/2015Global Ltd GullMajor ShareholderSell10,000$133.71$1,337,100.00View SEC Filing  
10/1/2015Myron W WentzDirectorSell10,000$131.85$1,318,500.00View SEC Filing  
9/10/2015Myron W WentzDirectorSell7,000$138.32$968,240.00View SEC Filing  
8/27/2015Deborah WooinsiderSell1,527$150.00$229,050.00View SEC Filing  
8/17/2015Paul A JonesCFOSell7,719$162.21$1,252,098.99View SEC Filing  
8/12/2015Myron W WentzDirectorSell7,000$159.84$1,118,880.00View SEC Filing  
7/8/2015Myron W WentzDirectorSell7,000$138.28$967,960.00View SEC Filing  
6/10/2015Myron W WentzDirectorSell7,000$133.75$936,250.00View SEC Filing  
6/9/2015Deborah WooInsiderSell3,656$132.06$482,811.36View SEC Filing  
5/14/2015Deborah WooInsiderSell3,569$124.00$442,556.00View SEC Filing  
5/12/2015Kevin GuestInsiderSell2,858$120.00$342,960.00View SEC Filing  
5/11/2015Daniel A MacugaInsiderSell4,231$125.64$531,582.84View SEC Filing  
5/11/2015Jim BrownCOOSell7,860$124.46$978,255.60View SEC Filing  
4/8/2015Global Ltd GullMajor ShareholderSell7,000$113.54$794,780.00View SEC Filing  
2/12/2015Robert AuciauxDirectorSell5,028$100.18$503,705.04View SEC Filing  
1/14/2015Myron W WentzDirectorSell7,000$101.32$709,240.00View SEC Filing  
12/16/2014Doug BraunCMOSell9,969$101.01$1,006,968.69View SEC Filing  
12/10/2014Myron W WentzDirectorSell102,755$100.25$10,301,188.75View SEC Filing  
12/8/2014Myron W WentzDirectorSell184,245$104.65$19,281,239.25View SEC Filing  
11/3/2014Dave WentzInsiderSell19,780$114.68$2,268,370.40View SEC Filing  
10/31/2014Ronald S PoelmanDirectorSell4,491$112.53$505,372.23View SEC Filing  
10/30/2014Paul A JonesCFOSell10,823$105.10$1,137,497.30View SEC Filing  
10/8/2014Myron W WentzDirectorSell7,000$76.52$535,640.00View SEC Filing  
9/10/2014Myron W WentzDirectorSell7,000$71.53$500,710.00View SEC Filing  
8/25/2014Dave WentzInsiderSell5,141$73.30$376,835.30View SEC Filing  
7/9/2014Myron W WentzDirectorSell7,000$78.95$552,650.00View SEC Filing  
6/13/2014Dave WentzInsiderSell5,301$75.51$400,278.51View SEC Filing  
6/11/2014Myron W WentzDirectorSell7,000$74.69$522,830.00View SEC Filing  
6/10/2014Daniel A MacugaInsiderSell6,654$75.01$499,116.54View SEC Filing  
5/30/2014Deborah WooInsiderSell1,028$73.00$75,044.00View SEC Filing  
5/28/2014Dave WentzInsiderSell5,141$73.03$375,447.23View SEC Filing  
5/28/2014Jerry G McclainDirectorSell1,217$72.12$87,770.04View SEC Filing  
5/22/2014Kevin GuestInsiderSell10,160$71.15$722,884.00View SEC Filing  
5/21/2014Kevin GuestInsiderSell2,475$71.00$175,725.00View SEC Filing  
5/19/2014James BrambleInsiderSell5,919$70.02$414,448.38View SEC Filing  
5/14/2014Myron WentzDirectorSell14,000$73.78$1,032,920.00View SEC Filing  
5/12/2014Deborah WooInsiderSell11,336$70.03$793,860.08View SEC Filing  
5/5/2014Deborah WooInsiderSell3,512$71.00$249,352.00View SEC Filing  
3/4/2014Myron WentzDirectorSell63,805$72.69$4,637,985.45View SEC Filing  
2/11/2014Doug BraunCMOSell8,139$70.46$573,473.94View SEC Filing  
11/13/2013Myron WentzDirectorSell7,000$67.68$473,760.00View SEC Filing  
10/9/2013Holdings Ltd Gullmajor shareholderSell7,000$80.08$560,560.00View SEC Filing  
9/11/2013Deborah WooInsiderSell1,340$79.01$105,873.40View SEC Filing  
9/11/2013Holdings Ltd Gullmajor shareholderSell7,000$78.19$547,330.00View SEC Filing  
9/5/2013Dave WentzInsiderSell13,704$77.93$1,067,952.72View SEC Filing  
9/3/2013Dave WentzInsiderSell32,174$78.10$2,512,789.40View SEC Filing  
8/14/2013Holdings Ltd Gullmajor shareholderSell7,000$80.34$562,380.00View SEC Filing  
8/1/2013Deborah WooInsiderSell1,386$85.00$117,810.00View SEC Filing  
7/26/2013Paul A JonesCFOSell5,047$78.01$393,716.47View SEC Filing  
7/25/2013Kevin GuestInsiderSell19,290$73.20$1,412,028.00View SEC Filing  
7/25/2013Ronald S PoelmanDirectorSell6,380$73.20$467,016.00View SEC Filing  
7/10/2013Holdings Ltd GullMajor ShareholderSell7,000$78.22$547,540.00View SEC Filing  
6/12/2013Holdings Ltd GullMajor ShareholderSell7,000$70.96$496,720.00View SEC Filing  
5/9/2013Robert AuciauxDirectorSell2,664$55.92$148,970.88View SEC Filing  
5/8/2013Holdings Ltd GullMajor ShareholderSell7,000$56.59$396,130.00View SEC Filing  
4/10/2013Holdings Ltd GullMajor ShareholderSell7,000$47.45$332,150.00View SEC Filing  
8/8/2012Myron W WentzDirectorSell7,000$44.21$309,470.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for USANA Health Sciences (NYSE:USNA)
Latest Headlines for USANA Health Sciences (NYSE:USNA)
Source:
DateHeadline
americanbankingnews.com logoJames Bramble Sells 18,298 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - August 22 at 1:14 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - August 22 at 12:44 PM
nasdaq.com logoUSANA To Expand In Four European Countries Beginning Mid-year 2018 = Quick Facts - Nasdaq
www.nasdaq.com - August 19 at 8:43 AM
finance.yahoo.com logoUSANA Breaks GUINNESS WORLD RECORDS™ Title at 25th Anniversary Event
finance.yahoo.com - August 18 at 8:24 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. :USNA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 17, 2017
finance.yahoo.com - August 18 at 8:24 AM
finance.yahoo.com logoUSANA Announces Plans To Expand In Four European Countries
finance.yahoo.com - August 18 at 8:24 AM
americanbankingnews.com logoMatthews International Corporation (MATW) versus USANA Health Sciences (USNA) Head-To-Head Comparison
www.americanbankingnews.com - August 11 at 2:44 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about USANA Health Sciences Inc.
finance.yahoo.com - August 10 at 3:27 PM
americanbankingnews.com logoGlobal Ltd Gull Sells 25,467 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock
www.americanbankingnews.com - August 2 at 7:46 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Major Shareholder Sells $824,166.43 in Stock
www.americanbankingnews.com - August 2 at 7:46 PM
americanbankingnews.com logoInsider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells 40,000 Shares of Stock
www.americanbankingnews.com - August 2 at 7:26 PM
seekingalpha.com logoThe Real USANA Revealed - Seeking Alpha
seekingalpha.com - August 2 at 8:21 AM
finance.yahoo.com logoUSANA Joins Forces with Philippines Sports Commission-Philippines Sports Institute
finance.yahoo.com - August 2 at 8:21 AM
americanbankingnews.com logoBidaskClub Downgrades USANA Health Sciences, Inc. (USNA) to Strong Sell
www.americanbankingnews.com - July 31 at 11:14 PM
americanbankingnews.com logoGilbert A. Fuller Sells 1,483 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - July 31 at 7:44 PM
americanbankingnews.com logoReviewing USANA Health Sciences (USNA) and Herbalife LTD. (HLF)
www.americanbankingnews.com - July 29 at 4:24 PM
americanbankingnews.com logoUSANA Health Sciences (USNA) & Avon Products (AVP) Head to Head Comparison
www.americanbankingnews.com - July 28 at 4:13 PM
finance.yahoo.com logoEdited Transcript of USNA earnings conference call or presentation 26-Jul-17 3:00pm GMT
finance.yahoo.com - July 27 at 8:59 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Given New $70.00 Price Target at Pivotal Research
www.americanbankingnews.com - July 26 at 7:27 PM
americanbankingnews.com logoUSANA Health Sciences (USNA) Board of Directors Approves Stock Repurchase Program
www.americanbankingnews.com - July 26 at 12:01 PM
streetinsider.com logoPre-Open Stock Movers 07/26: (TTPH) (IRBT) (AMD) Higher; (AMED) (USNA) (DVAX) Lower (more...) - StreetInsider.com
www.streetinsider.com - July 26 at 9:35 AM
marketwatch.com logoUSANA Health Sciences shares drop after company misses earnings, cuts outlook - MarketWatch
www.marketwatch.com - July 26 at 9:35 AM
finance.yahoo.com logoUSANA Health Sciences Reports Second Quarter Financial Results
finance.yahoo.com - July 26 at 9:35 AM
finance.yahoo.com logoUSANA Health Sciences shares drop after company misses earnings, cuts outlook
finance.yahoo.com - July 26 at 9:35 AM
finance.yahoo.com logoUSANA Health posts 2Q profit
finance.yahoo.com - July 26 at 9:35 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. breached its 50 day moving average in a Bullish Manner : USNA-US : July 26, 2017
finance.yahoo.com - July 26 at 9:35 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (NYSE:USNA) Issues Quarterly Earnings Results
www.americanbankingnews.com - July 25 at 10:13 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (NYSE:USNA) Issues FY17 Earnings Guidance
www.americanbankingnews.com - July 25 at 10:12 PM
americanbankingnews.com logoReviewing Unilever NV (UN) & USANA Health Sciences (USNA)
www.americanbankingnews.com - July 22 at 4:10 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) to Release Earnings on Tuesday
www.americanbankingnews.com - July 18 at 8:50 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (NYSE:USNA) Cut to "Sell" at BidaskClub
www.americanbankingnews.com - July 16 at 8:56 PM
americanbankingnews.com logoContrasting USANA Health Sciences (NYSE:USNA) & Unilever PLC (UL)
www.americanbankingnews.com - July 11 at 2:10 PM
finance.yahoo.com logoUSANA Health Sciences, Inc. – Value Analysis (NYSE:USNA) : July 10, 2017
finance.yahoo.com - July 11 at 9:04 AM
finance.yahoo.com logoUSANA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : USNA-US : July 7, 2017
finance.yahoo.com - July 8 at 3:51 PM
finance.yahoo.com logoUSANA Schedules Second Quarter Earnings Release and Conference Call
finance.yahoo.com - July 4 at 8:27 AM
finance.yahoo.com logoIncrease Your Energy Levels As You Support Your Liver Health
finance.yahoo.com - June 29 at 4:03 PM
finance.yahoo.com logoTwo USANA Executives Honored by Utah Business Magazine
finance.yahoo.com - June 22 at 8:03 PM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - June 20 at 4:10 PM
finance.yahoo.com logoGet Manly This June for National Men's Health Month
finance.yahoo.com - June 15 at 3:15 PM
americanbankingnews.com logoBidaskClub Upgrades USANA Health Sciences, Inc. (USNA) to Buy
www.americanbankingnews.com - June 13 at 7:16 PM
finance.yahoo.com logoUSANA CEO Elected To Direct Selling Association Board Of Directors
finance.yahoo.com - June 13 at 9:14 AM
finance.yahoo.com logoNew USANA Magnesium Supplement Receives Seal of Approval from Third Party Assessor
finance.yahoo.com - June 12 at 7:56 PM
americanbankingnews.com logoHead to Head Review: USANA Health Sciences (USNA) & Perrigo Company plc (PRGO)
www.americanbankingnews.com - June 11 at 10:04 AM
seekingalpha.com logoUSANA Health Sciences: Strong Moat, Highly Profitable And Growing Sales
seekingalpha.com - June 9 at 1:38 AM
finance.yahoo.com logoUSANA Makes Global Impact During Inaugural World Service Week
finance.yahoo.com - June 7 at 8:43 AM
finance.yahoo.com logoUSANA's Vitamin D Supplement Given Seal of Approval and Named Top Pick by Independent Tester
finance.yahoo.com - June 7 at 12:30 AM
americanbankingnews.com logoCritical Analysis: Perrigo Company plc (PRGO) and USANA Health Sciences (USNA)
www.americanbankingnews.com - June 4 at 7:28 AM
americanbankingnews.com logoUSANA Health Sciences, Inc. (USNA) Director Sells $2,599,600.00 in Stock
www.americanbankingnews.com - June 2 at 7:43 PM
finance.yahoo.com logoETFs with exposure to USANA Health Sciences, Inc. : June 1, 2017
finance.yahoo.com - June 2 at 3:13 AM
americanbankingnews.com logoPaul A. Jones Sells 9,851 Shares of USANA Health Sciences, Inc. (USNA) Stock
www.americanbankingnews.com - June 1 at 4:28 PM

Social

Chart

USANA Health Sciences (USNA) Chart for Wednesday, August, 23, 2017

This page was last updated on 8/23/2017 by MarketBeat.com Staff